Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbie L McLeod

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature Communications|July 19, 2014
Treatment of acute lung injury by targeting MG53-mediated cell membrane repairYanlin Jia, Ken Chen, Peihui Lin, et al.
European Journal of Pharmacology|September 10, 2013
Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent modelsGissela B Lieber, Xiomara Fernandez, Garfield G Mingo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 InflammationRobbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
BMC Musculoskeletal Disorders|December 6, 2014
Etanercept ameliorates inflammation and pain in a novel mono-arthritic multi-flare model of streptococcal cell wall induced arthritisKalyan Chakravarthy, Robert Faltus, Gain Robinson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 10, 2016
Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose PredictionsMichael Caniga, Antonio Cabal, Khamir Mehta, et al.
European Journal of Pharmacology|September 28, 2014
Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammationMalgorzata A Gil, Michael Caniga, Janice D Woodhouse, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxietyGinny D Ho, John Anthes, Ana Bercovici, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
European Journal of Pharmacology|December 17, 2009
Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical modelsRobbie L McLeod, Deen B Tulshian, Donald C Bolser, et al.
Journal of Medicinal Chemistry|April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved TolerabilityJoey L Methot, Hua Zhou, Sam D Kattar, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature Communications|July 19, 2014
Treatment of acute lung injury by targeting MG53-mediated cell membrane repairYanlin Jia, Ken Chen, Peihui Lin, et al.
European Journal of Pharmacology|September 10, 2013
Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent modelsGissela B Lieber, Xiomara Fernandez, Garfield G Mingo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2019
Characterizing Pharmacokinetic-Pharmacodynamic Relationships and Efficacy of PI3K<i>δ</i> Inhibitors in Respiratory Models of TH2 and TH1 InflammationRobbie L McLeod, Malgorzata A Gil, Dapeng Chen, et al.
BMC Musculoskeletal Disorders|December 6, 2014
Etanercept ameliorates inflammation and pain in a novel mono-arthritic multi-flare model of streptococcal cell wall induced arthritisKalyan Chakravarthy, Robert Faltus, Gain Robinson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 10, 2016
Preclinical Experimental and Mathematical Approaches for Assessing Effective Doses of Inhaled Drugs, Using Mometasone to Support Human Dose PredictionsMichael Caniga, Antonio Cabal, Khamir Mehta, et al.
European Journal of Pharmacology|September 28, 2014
Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammationMalgorzata A Gil, Michael Caniga, Janice D Woodhouse, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxietyGinny D Ho, John Anthes, Ana Bercovici, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2011
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A)Michel R Corboz, Maria A Rivelli, Kevin D McCormick, et al.
European Journal of Pharmacology|December 17, 2009
Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical modelsRobbie L McLeod, Deen B Tulshian, Donald C Bolser, et al.
Journal of Medicinal Chemistry|April 16, 2019
Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved TolerabilityJoey L Methot, Hua Zhou, Sam D Kattar, et al.
Pageof 5